Classify genotoxic impurities with confidence
Lhasa infographic, published 22nd May 2025.
Discover how our in silico tools support regulatory-ready genotoxic impurity risk assessments.
Access this infographic:
Struggling with complex genotoxic impurity assessments?
Regulatory frameworks like ICH M7 and EFSA (2016) demand scientifically robust and defensible decisions — but traditional in vitro and in vivo testing can be time-consuming and costly.
At Lhasa Limited, we work alongside industry and regulators to make this process easier, faster and more consistent. Our in silico solutions support toxicologists in confidently predicting mutagenicity and assessing chromosome damage — reducing reliance on lab testing while staying aligned with regulatory expectations.
Download our infographic to explore how Lhasa supports informed, efficient genotoxicity risk assessments.